NEW: PrOSPeCT extended through to 2028/29 | $71M Federal Government funding supporting an additional 25,000 patient referrals nationwide

Omico's Clinical Portal

Bringing comprehensive genomic profiling to patients with advanced and incurable cancer and helping identify potential treatments or clinical trials.
Comprehensive Genomic Profiling (CGP) Panels

Omico are partnered with various NATA accredited laboratories that perform CGP for CaSP. Details of genes included and/or the technical specifications are listed below:

TSO-500

FoundationOne CDx technical specifications

Sonic Genetics CGP gene list

FoundationOne Liquid CDx technical specifications

Alert